\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ no\\ treatment\\ or\\ followup\\ is\\ needed\\.\ \(1\)\
\-\ ultrasound\\ shows\\ a\\ heterogeneous\\ isoechoic\\ mass\\ with\\ echogenic\\ rim\\.\ \(1\)\
\-\ the\\ peripheral\\ nodular\\ enhancement\\ on\\ ct\\ is\\ pathognomonic\\ of\\ a\\ hemangioma\ \(0\)\
\-\ the\\ u\\/s\\ characteristics\\ are\\ nonspecific\\,\\ and\\ a\\ reasonable\\ differential\\ diagnosis\\ would\\ include\ \(0\)\
\-\ hemangioma\\,\\ fnh\\,\\ adenoma\\,\\ hcc\\,\\ metastasis\\,\\ and\\ lymphoma\\.\ \(0\)\
\-\ 49\\ year\\ old\\ female\\ with\\ incidental\\ lesion\\ on\\ ct\\ please\\ evaluate\\ with\\ ultrasound\\.\ \(0\)\
\-\ the\\ liver\\ lesion\\ was\\ a\\ nonspecific\\ incidental\\ finding\\ on\\ an\\ earlier\\ unenhanced\\ ct\\ study\\.\\ \\ at\\ that\\ time\\ an\\ ultrasound\\ was\\ recommended\\ for\\ further\\ evaluation\\.\\ \\ however\\,\\ on\\ the\\ same\\ day\\ as\\ the\\ ultrasound\\,\\ the\\ patient\\ was\\ undergoing\\ a\\ contrast\\ ct\\ of\\ the\\ chest\\ contrast\\ for\\ different\\ reasons\\.\\ \\ the\\ submitted\\ ct\\ image\\ is\\ from\\ that\\ study\\.\\ although\\ not\\ a\\ 3\\ phase\\ ct\\,\\ the\\ characteristics\\ shown\\ on\\ the\\ single\\ obtained\\ phase\\ are\\ sufficient\\ for\\ the\\ diagnosis\\ of\\ a\\ hemangioma\\.\\ the\\ ct\\ and\\ us\\ images\\ were\\ made\\ available\\ at\\ the\\ same\\ time\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemangioma\\:\\ 0\\.06900553283498283\ \(0\)\
\-\ ultrasound\\:\\ 0\\.06108729120497117\ \(0\)\
\-\ nonspecific\\:\\ 0\\.052972021881565065\ \(0\)\
\-\ characteristics\\:\\ 0\\.05121891846383931\ \(0\)\
\-\ ct\\:\\ 0\\.05040437092617048\ \(0\)\
\-\ phase\\:\\ 0\\.04843045636590069\ \(0\)\
\-\ same\\:\\ 0\\.042436308424602484\ \(0\)\
\-\ incidental\\:\\ 0\\.038985404794943085\ \(0\)\
\-\ fnh\\:\\ 0\\.038136215507099384\ \(0\)\
\-\ isoechoic\\:\\ 0\\.03720759695392313\ \(0\)\
\-\ u\\/s\\:\\ 0\\.03640319097425733\ \(0\)\
\-\ reasonable\\:\\ 0\\.03396063008203947\ \(0\)\
\-\ hcc\\:\\ 0\\.03396063008203947\ \(0\)\
\-\ study\\:\\ 0\\.03387507658867421\ \(0\)\
\-\ sufficient\\:\\ 0\\.03204223411144589\ \(0\)\
\-\ unenhanced\\:\\ 0\\.03168777326793425\ \(0\)\
\-\ reasons\\:\\ 0\\.03058945063664536\ \(0\)\
\-\ submitted\\:\\ 0\\.0304477006522466\ \(0\)\
\-\ time\\:\\ 0\\.029079532858304974\ \(0\)\
\-\ 49\\:\\ 0\\.02854205409675168\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.02786664868638598\ \(0\)\
\-\ echogenic\\:\\ 0\\.025609459231919655\ \(0\)\
\-\ different\\:\\ 0\\.025485246658409195\ \(0\)\
\-\ earlier\\:\\ 0\\.025424087794168125\ \(0\)\
\-\ undergoing\\:\\ 0\\.025244250666760403\ \(0\)\
\-\ followup\\:\\ 0\\.02457421672031327\ \(0\)\
\-\ diagnosis\\:\\ 0\\.023641196756390603\ \(0\)\
\-\ contrast\\:\\ 0\\.023045490202504886\ \(0\)\
\-\ please\\:\\ 0\\.02284119218747122\ \(0\)\
\-\ needed\\:\\ 0\\.022420290500962267\ \(0\)\
\-\ on\\:\\ 0\\.02180394615558518\ \(0\)\
\-\ rim\\:\\ 0\\.021789285498196826\ \(0\)\
\-\ nodular\\:\\ 0\\.02159283016332477\ \(0\)\
\-\ us\\:\\ 0\\.02159283016332477\ \(0\)\
\-\ adenoma\\:\\ 0\\.02149695392654224\ \(0\)\
\-\ recommended\\:\\ 0\\.02134047509278766\ \(0\)\
\-\ lesion\\:\\ 0\\.020970544891571744\ \(0\)\
\-\ single\\:\\ 0\\.02086542343668935\ \(0\)\
\-\ evaluate\\:\\ 0\\.020808591917211284\ \(0\)\
\-\ shown\\:\\ 0\\.020641245145481914\ \(0\)\
\-\ made\\:\\ 0\\.020505255253683484\ \(0\)\
\-\ metastasis\\:\\ 0\\.019269562206626064\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.018928886486716902\ \(0\)\
\-\ n\\/a\\:\\ 0\\.01864582317686197\ \(0\)\
\-\ peripheral\\:\\ 0\\.018626104349482635\ \(0\)\
\-\ would\\:\\ 0\\.018319077580855964\ \(0\)\
\-\ obtained\\:\\ 0\\.01830039819725206\ \(0\)\
\-\ was\\:\\ 0\\.01786043714844012\ \(0\)\
\-\ that\\:\\ 0\\.01778290034408221\ \(0\)\
\-\ liver\\:\\ 0\\.017748322354414\ \(0\)\
\-\ although\\:\\ 0\\.01738511614805183\ \(0\)\
\-\ available\\:\\ 0\\.01730553643879396\ \(0\)\
\-\ a\\:\\ 0\\.016724088028495232\ \(0\)\
\-\ finding\\:\\ 0\\.01659073195806314\ \(0\)\
\-\ further\\:\\ 0\\.016370145432531676\ \(0\)\
\-\ differential\\:\\ 0\\.016343131502126084\ \(0\)\
\-\ day\\:\\ 0\\.016343131502126084\ \(0\)\
\-\ image\\:\\ 0\\.01607945280902169\ \(0\)\
\-\ evaluation\\:\\ 0\\.014953245757992818\ \(0\)\
\-\ lymphoma\\:\\ 0\\.014712039966201722\ \(0\)\
\-\ \\,\\:\\ 0\\.014677051744913171\ \(0\)\
\-\ include\\:\\ 0\\.014440683662833053\ \(0\)\
\-\ however\\:\\ 0\\.014333542503596811\ \(0\)\
\-\ an\\:\\ 0\\.014236926075719638\ \(0\)\
\-\ shows\\:\\ 0\\.014152853612824572\ \(0\)\
\-\ are\\:\\ 0\\.014034624970236166\ \(0\)\
\-\ at\\:\\ 0\\.013948953648573893\ \(0\)\
\-\ enhancement\\:\\ 0\\.013798125097126723\ \(0\)\
\-\ for\\:\\ 0\\.013176653288723767\ \(0\)\
\-\ chest\\:\\ 0\\.012317644578659751\ \(0\)\
\-\ 3\\:\\ 0\\.012054069437991203\ \(0\)\
\-\ were\\:\\ 0\\.011688471907770611\ \(0\)\
\-\ the\\:\\ 0\\.010826751211729732\ \(0\)\
\-\ female\\:\\ 0\\.010582893201492975\ \(0\)\
\-\ treatment\\:\\ 0\\.010419379274704139\ \(0\)\
\-\ is\\:\\ 0\\.010161881537073354\ \(0\)\
\-\ images\\:\\ 0\\.009875083686441893\ \(0\)\
\-\ as\\:\\ 0\\.007786611481289927\ \(0\)\
\-\ from\\:\\ 0\\.0076291308021338095\ \(0\)\
\-\ not\\:\\ 0\\.007438666697240575\ \(0\)\
\-\ mass\\:\\ 0\\.00715940365631063\ \(0\)\
\-\ or\\:\\ 0\\.006033269572070527\ \(0\)\
\-\ year\\:\\ 0\\.0057596702968247876\ \(0\)\
\-\ old\\:\\ 0\\.005270690342543702\ \(0\)\
\-\ no\\:\\ 0\\.005183398498215675\ \(0\)\
\-\ patient\\:\\ 0\\.0051601923549180004\ \(0\)\
\-\ and\\:\\ 0\\.00325317480238949\ \(0\)\
\-\ \\.\\:\\ 0\\.0021385262709244742\ \(0\)\
\-\ with\\:\\ 0\\.0021145333028293324\ \(0\)\
\-\ of\\:\\ 0\\.0021054903758672607\ \(0\)\
